Aclarion, Inc. (NASDAQ: ACONW) Stock Competitors & Peer Comparison

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while GEHCV trades at $56.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas GEHCV's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.59%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, ACONW is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check GEHCV's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, TEM has a market cap of 13.5B. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while TEM trades at $77.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas TEM's P/E ratio is -154.38. In terms of profitability, ACONW's ROE is -0.59%, compared to TEM's ROE of -0.55%. Regarding short-term risk, ACONW is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check TEM's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, BTSG has a market cap of 11.1B. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while BTSG trades at $56.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas BTSG's P/E ratio is 38.47. In terms of profitability, ACONW's ROE is -0.59%, compared to BTSG's ROE of +0.15%. Regarding short-term risk, ACONW is less volatile compared to BTSG. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check BTSG's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, BTSGU has a market cap of 10.9B. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while BTSGU trades at $187.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas BTSGU's P/E ratio is 126.58. In terms of profitability, ACONW's ROE is -0.59%, compared to BTSGU's ROE of +0.15%. Regarding short-term risk, ACONW is less volatile compared to BTSGU. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check BTSGU's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while SGFY trades at $30.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas SGFY's P/E ratio is 70.91. In terms of profitability, ACONW's ROE is -0.59%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, ACONW is less volatile compared to SGFY. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check SGFY's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, HQY has a market cap of 7.7B. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while HQY trades at $91.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas HQY's P/E ratio is 21.44. In terms of profitability, ACONW's ROE is -0.59%, compared to HQY's ROE of +0.11%. Regarding short-term risk, ACONW is less volatile compared to HQY. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check HQY's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, HNGE has a market cap of 7.3B. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while HNGE trades at $94.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas HNGE's P/E ratio is 50.36. In terms of profitability, ACONW's ROE is -0.59%, compared to HNGE's ROE of +0.30%. Regarding short-term risk, ACONW is less volatile compared to HNGE. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check HNGE's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, RCM has a market cap of 6B. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while RCM trades at $14.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas RCM's P/E ratio is -102.21. In terms of profitability, ACONW's ROE is -0.59%, compared to RCM's ROE of +0.00%. Regarding short-term risk, ACONW is similarly volatile compared to RCM. This indicates similar risk in terms of short-term price fluctuations for ACONW.Check RCM's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, DOCS has a market cap of 5B. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while DOCS trades at $26.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas DOCS's P/E ratio is 17.32. In terms of profitability, ACONW's ROE is -0.59%, compared to DOCS's ROE of +0.17%. Regarding short-term risk, ACONW is less volatile compared to DOCS. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check DOCS's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, WAY has a market cap of 4.9B. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while WAY trades at $25.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas WAY's P/E ratio is 16.97. In terms of profitability, ACONW's ROE is -0.59%, compared to WAY's ROE of +0.04%. Regarding short-term risk, ACONW is less volatile compared to WAY. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check WAY's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, HTFL has a market cap of 4.3B. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while HTFL trades at $50.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas HTFL's P/E ratio is -24.96. In terms of profitability, ACONW's ROE is -0.59%, compared to HTFL's ROE of -0.42%. Regarding short-term risk, ACONW is less volatile compared to HTFL. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check HTFL's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while ONEM trades at $16.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas ONEM's P/E ratio is -7.77. In terms of profitability, ACONW's ROE is -0.59%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, ACONW is less volatile compared to ONEM. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check ONEM's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, PRVA has a market cap of 2.5B. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while PRVA trades at $19.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas PRVA's P/E ratio is 92.67. In terms of profitability, ACONW's ROE is -0.59%, compared to PRVA's ROE of +0.00%. Regarding short-term risk, ACONW is less volatile compared to PRVA. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check PRVA's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while NXGN trades at $23.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas NXGN's P/E ratio is -266.00. In terms of profitability, ACONW's ROE is -0.59%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, ACONW is less volatile compared to NXGN. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check NXGN's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, OMCL has a market cap of 1.5B. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while OMCL trades at $33.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas OMCL's P/E ratio is 17.37. In terms of profitability, ACONW's ROE is -0.59%, compared to OMCL's ROE of +0.03%. Regarding short-term risk, ACONW is less volatile compared to OMCL. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check OMCL's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, CERT has a market cap of 1.4B. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while CERT trades at $8.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas CERT's P/E ratio is 22.08. In terms of profitability, ACONW's ROE is -0.59%, compared to CERT's ROE of -0.07%. Regarding short-term risk, ACONW is less volatile compared to CERT. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check CERT's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while AGTI trades at $10.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas AGTI's P/E ratio is -71.79. In terms of profitability, ACONW's ROE is -0.59%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, ACONW is less volatile compared to AGTI. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check AGTI's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, OMDA has a market cap of 1.3B. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while OMDA trades at $21.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas OMDA's P/E ratio is 305.29. In terms of profitability, ACONW's ROE is -0.59%, compared to OMDA's ROE of +0.02%. Regarding short-term risk, ACONW is less volatile compared to OMDA. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check OMDA's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, GDRX has a market cap of 1.2B. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while GDRX trades at $3.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas GDRX's P/E ratio is 10.75. In terms of profitability, ACONW's ROE is -0.59%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, ACONW is less volatile compared to GDRX. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check GDRX's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, TDOC has a market cap of 1.2B. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while TDOC trades at $6.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas TDOC's P/E ratio is -6.42. In terms of profitability, ACONW's ROE is -0.59%, compared to TDOC's ROE of -0.13%. Regarding short-term risk, ACONW is less volatile compared to TDOC. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check TDOC's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while CCLDO trades at $27.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas CCLDO's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.59%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, ACONW is similarly volatile compared to CCLDO. This indicates similar risk in terms of short-term price fluctuations for ACONW.Check CCLDO's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, HSTM has a market cap of 847.5M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while HSTM trades at $29.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas HSTM's P/E ratio is 40.29. In terms of profitability, ACONW's ROE is -0.59%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, ACONW is less volatile compared to HSTM. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check HSTM's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, SOPH has a market cap of 677M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while SOPH trades at $8.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas SOPH's P/E ratio is -7.27. In terms of profitability, ACONW's ROE is -0.59%, compared to SOPH's ROE of -1.37%. Regarding short-term risk, ACONW is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check SOPH's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while MPLN-WT trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.59%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, ACONW is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check MPLN-WT's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, PHR has a market cap of 624.3M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while PHR trades at $10.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas PHR's P/E ratio is 36.07. In terms of profitability, ACONW's ROE is -0.59%, compared to PHR's ROE of +0.03%. Regarding short-term risk, ACONW is less volatile compared to PHR. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check PHR's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while ACCD trades at $7.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas ACCD's P/E ratio is -3.08. In terms of profitability, ACONW's ROE is -0.59%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, ACONW is similarly volatile compared to ACCD. This indicates similar risk in terms of short-term price fluctuations for ACONW.Check ACCD's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while SHCR trades at $1.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas SHCR's P/E ratio is -3.76. In terms of profitability, ACONW's ROE is -0.59%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, ACONW is less volatile compared to SHCR. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check SHCR's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, CTEV has a market cap of 502.1M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while CTEV trades at $29.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas CTEV's P/E ratio is -1.73. In terms of profitability, ACONW's ROE is -0.59%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, ACONW is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check CTEV's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, NRC has a market cap of 492.7M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while NRC trades at $21.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas NRC's P/E ratio is 26.66. In terms of profitability, ACONW's ROE is -0.59%, compared to NRC's ROE of +0.48%. Regarding short-term risk, ACONW is less volatile compared to NRC. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check NRC's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, EVH has a market cap of 426.3M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while EVH trades at $3.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas EVH's P/E ratio is 29.15. In terms of profitability, ACONW's ROE is -0.59%, compared to EVH's ROE of -0.99%. Regarding short-term risk, ACONW is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check EVH's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, CARL has a market cap of 419.2M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while CARL trades at $15.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas CARL's P/E ratio is -10.78. In terms of profitability, ACONW's ROE is -0.59%, compared to CARL's ROE of -0.38%. Regarding short-term risk, ACONW is less volatile compared to CARL. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check CARL's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while SLGC trades at $2.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas SLGC's P/E ratio is -3.04. In terms of profitability, ACONW's ROE is -0.59%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, ACONW is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check SLGC's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while SLGCW trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, ACONW's ROE is -0.59%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, ACONW is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check SLGCW's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while TBRG trades at $26.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas TBRG's P/E ratio is 9.37. In terms of profitability, ACONW's ROE is -0.59%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, ACONW is less volatile compared to TBRG. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check TBRG's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while MPLN trades at $23.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas MPLN's P/E ratio is -0.23. In terms of profitability, ACONW's ROE is -0.59%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, ACONW is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check MPLN's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, SY has a market cap of 367.4M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while SY trades at $2.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas SY's P/E ratio is -8.48. In terms of profitability, ACONW's ROE is -0.59%, compared to SY's ROE of -0.16%. Regarding short-term risk, ACONW is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check SY's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while TRHC trades at $10.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas TRHC's P/E ratio is -4.27. In terms of profitability, ACONW's ROE is -0.59%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, ACONW is less volatile compared to TRHC. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check TRHC's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while SMFR trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas SMFR's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.59%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, ACONW is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check SMFR's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, AMWL has a market cap of 224.2M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while AMWL trades at $13.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas AMWL's P/E ratio is -2.98. In terms of profitability, ACONW's ROE is -0.59%, compared to AMWL's ROE of -0.33%. Regarding short-term risk, ACONW is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check AMWL's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, SPOK has a market cap of 219.9M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while SPOK trades at $10.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas SPOK's P/E ratio is 17.55. In terms of profitability, ACONW's ROE is -0.59%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, ACONW is less volatile compared to SPOK. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check SPOK's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, LFMD has a market cap of 159.6M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while LFMD trades at $3.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas LFMD's P/E ratio is -6.60. In terms of profitability, ACONW's ROE is -0.59%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, ACONW is less volatile compared to LFMD. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check LFMD's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, LFMDP has a market cap of 159.2M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while LFMDP trades at $23.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas LFMDP's P/E ratio is -719.57. In terms of profitability, ACONW's ROE is -0.59%, compared to LFMDP's ROE of -1.79%. Regarding short-term risk, ACONW is less volatile compared to LFMDP. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check LFMDP's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, OPRX has a market cap of 143M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while OPRX trades at $7.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas OPRX's P/E ratio is 6.99. In terms of profitability, ACONW's ROE is -0.59%, compared to OPRX's ROE of +0.04%. Regarding short-term risk, ACONW is less volatile compared to OPRX. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check OPRX's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, HCAT has a market cap of 139.7M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while HCAT trades at $1.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas HCAT's P/E ratio is 9.45. In terms of profitability, ACONW's ROE is -0.59%, compared to HCAT's ROE of -1.30%. Regarding short-term risk, ACONW is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check HCAT's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while CPSI trades at $9.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas CPSI's P/E ratio is -183.80. In terms of profitability, ACONW's ROE is -0.59%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, ACONW is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check CPSI's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while AUGX trades at $2.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas AUGX's P/E ratio is -4.99. In terms of profitability, ACONW's ROE is -0.59%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, ACONW is less volatile compared to AUGX. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check AUGX's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, DH has a market cap of 93.9M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while DH trades at $0.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas DH's P/E ratio is 3.42. In terms of profitability, ACONW's ROE is -0.59%, compared to DH's ROE of -0.79%. Regarding short-term risk, ACONW is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check DH's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, CCLD has a market cap of 91.4M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while CCLD trades at $2.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas CCLD's P/E ratio is 8.27. In terms of profitability, ACONW's ROE is -0.59%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, ACONW is less volatile compared to CCLD. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check CCLD's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, WORX has a market cap of 88M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while WORX trades at $5.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas WORX's P/E ratio is -6.40. In terms of profitability, ACONW's ROE is -0.59%, compared to WORX's ROE of -0.35%. Regarding short-term risk, ACONW is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check WORX's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while FORA trades at $2.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas FORA's P/E ratio is -24.11. In terms of profitability, ACONW's ROE is -0.59%, compared to FORA's ROE of -0.17%. Regarding short-term risk, ACONW is similarly volatile compared to FORA. This indicates similar risk in terms of short-term price fluctuations for ACONW.Check FORA's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while CCLDP trades at $19.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas CCLDP's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.59%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, ACONW is less volatile compared to CCLDP. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check CCLDP's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, ONMD has a market cap of 37.7M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while ONMD trades at $0.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas ONMD's P/E ratio is -4.13. In terms of profitability, ACONW's ROE is -0.59%, compared to ONMD's ROE of +2.35%. Regarding short-term risk, ACONW is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check ONMD's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while SNCE trades at $5.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas SNCE's P/E ratio is -0.27. In terms of profitability, ACONW's ROE is -0.59%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, ACONW is less volatile compared to SNCE. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check SNCE's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while AKLI trades at $0.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas AKLI's P/E ratio is -0.71. In terms of profitability, ACONW's ROE is -0.59%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, ACONW is less volatile compared to AKLI. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check AKLI's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while SHLT trades at $2.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas SHLT's P/E ratio is -3.87. In terms of profitability, ACONW's ROE is -0.59%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, ACONW is similarly volatile compared to SHLT. This indicates similar risk in terms of short-term price fluctuations for ACONW.Check SHLT's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while SHCRW trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, ACONW's ROE is -0.59%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, ACONW is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check SHCRW's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, ONMDW has a market cap of 26.3M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while ONMDW trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas ONMDW's P/E ratio is -0.19. In terms of profitability, ACONW's ROE is -0.59%, compared to ONMDW's ROE of +2.35%. Regarding short-term risk, ACONW is less volatile compared to ONMDW. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check ONMDW's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while STRM trades at $5.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas STRM's P/E ratio is -2.40. In terms of profitability, ACONW's ROE is -0.59%, compared to STRM's ROE of -0.65%. Regarding short-term risk, ACONW is similarly volatile compared to STRM. This indicates similar risk in terms of short-term price fluctuations for ACONW.Check STRM's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while RNLX trades at $0.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas RNLX's P/E ratio is -0.33. In terms of profitability, ACONW's ROE is -0.59%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, ACONW is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check RNLX's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while LIFW trades at $3.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas LIFW's P/E ratio is -0.02. In terms of profitability, ACONW's ROE is -0.59%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, ACONW is similarly volatile compared to LIFW. This indicates similar risk in terms of short-term price fluctuations for ACONW.Check LIFW's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while BBLN trades at $0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas BBLN's P/E ratio is -0.04. In terms of profitability, ACONW's ROE is -0.59%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, ACONW is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check BBLN's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, BFRG has a market cap of 10.7M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while BFRG trades at $0.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas BFRG's P/E ratio is -1.25. In terms of profitability, ACONW's ROE is -0.59%, compared to BFRG's ROE of -1.50%. Regarding short-term risk, ACONW is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check BFRG's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while ETAO trades at $1.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas ETAO's P/E ratio is -0.01. In terms of profitability, ACONW's ROE is -0.59%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, ACONW is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check ETAO's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, MGRX has a market cap of 7.3M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while MGRX trades at $0.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas MGRX's P/E ratio is -0.32. In terms of profitability, ACONW's ROE is -0.59%, compared to MGRX's ROE of -1.06%. Regarding short-term risk, ACONW is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check MGRX's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while UPH-WT trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.59%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, ACONW is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check UPH-WT's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while UPH trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas UPH's P/E ratio is -0.07. In terms of profitability, ACONW's ROE is -0.59%, compared to UPH's ROE of -1.05%. Regarding short-term risk, ACONW is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check UPH's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while PEAR trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas PEAR's P/E ratio is -0.08. In terms of profitability, ACONW's ROE is -0.59%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, ACONW is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check PEAR's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while PEARW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas PEARW's P/E ratio is -0.00. In terms of profitability, ACONW's ROE is -0.59%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, ACONW is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check PEARW's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while OTRK trades at $0.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas OTRK's P/E ratio is -0.02. In terms of profitability, ACONW's ROE is -0.59%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, ACONW is similarly volatile compared to OTRK. This indicates similar risk in terms of short-term price fluctuations for ACONW.Check OTRK's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, BFRGW has a market cap of 1.9M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while BFRGW trades at $0.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas BFRGW's P/E ratio is -0.31. In terms of profitability, ACONW's ROE is -0.59%, compared to BFRGW's ROE of -1.50%. Regarding short-term risk, ACONW is less volatile compared to BFRGW. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check BFRGW's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while CMAX trades at $0.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas CMAX's P/E ratio is -0.00. In terms of profitability, ACONW's ROE is -0.59%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, ACONW is similarly volatile compared to CMAX. This indicates similar risk in terms of short-term price fluctuations for ACONW.Check CMAX's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, ACON has a market cap of 1.4M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while ACON trades at $2.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas ACON's P/E ratio is -0.29. In terms of profitability, ACONW's ROE is -0.59%, compared to ACON's ROE of -0.59%. Regarding short-term risk, ACONW is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check ACON's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while LIFWZ trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.59%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, ACONW is similarly volatile compared to LIFWZ. This indicates similar risk in terms of short-term price fluctuations for ACONW.Check LIFWZ's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, HCTI has a market cap of 999K. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while HCTI trades at $0.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas HCTI's P/E ratio is -0.11. In terms of profitability, ACONW's ROE is -0.59%, compared to HCTI's ROE of -0.56%. Regarding short-term risk, ACONW is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check HCTI's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, VSEEW has a market cap of 560.3K. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while VSEEW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, ACONW's ROE is -0.59%, compared to VSEEW's ROE of -4.01%. Regarding short-term risk, ACONW is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check VSEEW's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while MSPRZ trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.59%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, ACONW is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check MSPRZ's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, VSEE has a market cap of 307.6K. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while VSEE trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas VSEE's P/E ratio is -0.04. In terms of profitability, ACONW's ROE is -0.59%, compared to VSEE's ROE of -4.01%. Regarding short-term risk, ACONW is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check VSEE's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while KERNW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas KERNW's P/E ratio is -0.00. In terms of profitability, ACONW's ROE is -0.59%, compared to KERNW's ROE of -0.20%. Regarding short-term risk, ACONW is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check KERNW's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while KERN trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas KERN's P/E ratio is -0.01. In terms of profitability, ACONW's ROE is -0.59%, compared to KERN's ROE of -0.20%. Regarding short-term risk, ACONW is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check KERN's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while LIFWW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas LIFWW's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.59%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, ACONW is similarly volatile compared to LIFWW. This indicates similar risk in terms of short-term price fluctuations for ACONW.Check LIFWW's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while CMAXW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas CMAXW's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.59%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, ACONW is similarly volatile compared to CMAXW. This indicates similar risk in terms of short-term price fluctuations for ACONW.Check CMAXW's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, ZCMD has a market cap of 35.8K. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while ZCMD trades at $1.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas ZCMD's P/E ratio is -0.03. In terms of profitability, ACONW's ROE is -0.59%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, ACONW is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check ZCMD's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, CSLT has a market cap of 0. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while CSLT trades at $2.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas CSLT's P/E ratio is -37.27. In terms of profitability, ACONW's ROE is -0.59%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, ACONW is less volatile compared to CSLT. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check CSLT's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, CERN has a market cap of 0. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while CERN trades at $94.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas CERN's P/E ratio is 55.84. In terms of profitability, ACONW's ROE is -0.59%, compared to CERN's ROE of +0.14%. Regarding short-term risk, ACONW is less volatile compared to CERN. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check CERN's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, CHNG has a market cap of 0. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while CHNG trades at $27.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas CHNG's P/E ratio is -152.72. In terms of profitability, ACONW's ROE is -0.59%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, ACONW is less volatile compared to CHNG. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check CHNG's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while SMFRW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas SMFRW's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.59%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, ACONW is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check SMFRW's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, CNVY has a market cap of 0. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while CNVY trades at $10.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas CNVY's P/E ratio is -71.50. In terms of profitability, ACONW's ROE is -0.59%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, ACONW is less volatile compared to CNVY. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check CNVY's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, IMS has a market cap of 0. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while IMS trades at $31.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas IMS's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.59%, compared to IMS's ROE of +0.27%. Regarding short-term risk, ACONW is less volatile compared to IMS. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check IMS's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, NAVA has a market cap of 0. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while NAVA trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas NAVA's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.59%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, ACONW is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for ACONW.Check NAVA's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, MTBC has a market cap of 0. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while MTBC trades at $3.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas MTBC's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.59%, compared to MTBC's ROE of +0.19%. Regarding short-term risk, ACONW is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check MTBC's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while MTBCO trades at $25.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas MTBCO's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.59%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, ACONW is less volatile compared to MTBCO. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check MTBCO's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while CHNGU trades at $73.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas CHNGU's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.59%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, ACONW is less volatile compared to CHNGU. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check CHNGU's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, AFFX has a market cap of 0. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while AFFX trades at $14.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas AFFX's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.59%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, ACONW is less volatile compared to AFFX. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check AFFX's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while MSPRV trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas MSPRV's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.59%, compared to MSPRV's ROE of N/A. Regarding short-term risk, ACONW is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check MSPRV's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, KURIU has a market cap of 0. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while KURIU trades at $9.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas KURIU's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.59%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, ACONW is less volatile compared to KURIU. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check KURIU's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, NH has a market cap of 0. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while NH trades at $1.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas NH's P/E ratio is -0.12. In terms of profitability, ACONW's ROE is -0.59%, compared to NH's ROE of +0.35%. Regarding short-term risk, ACONW is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check NH's competition here

Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ACONW stands at 15.7K. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, ACONW is priced at $0.03 on the NASDAQ, while MTBCP trades at $26.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ACONW currently has a P/E ratio of N/A, whereas MTBCP's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.59%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, ACONW is less volatile compared to MTBCP. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check MTBCP's competition here